Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar-Reference-Cited by-同舟云学术

Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar

Published:2018-08-10 Issue:6 Volume:40 Page:542-550
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Gutman Sarah J¹²³,Costello Benedict T¹²³,Papapostolou Stavroula¹³,Voskoboinik Aleksandr¹²⁴⁵,Iles Leah¹²,Ja Johnson¹,Hare James L¹²,Ellims Andris¹,Kistler Peter M¹²³⁵,Marwick Thomas H¹²³,Taylor Andrew J¹²³

Affiliation:

1. Department of Cardiology, The Alfred Hospital, Commercial Road, Melbourne, Australia

2. Imaging Research, Baker Heart and Diabetes Institute, Commercial Road, Melbourne, Australia

3. Department of Medicine, Nursing and Health Sciences, Monash University, Wellington Road, Melbourne, Australia

4. Department of Cardiology, The Royal Melbourne Hospital, Grattan Street, Melbourne, Australia

5. Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Grattan Street, Melbourne, Australia

Funder

National Health and Medical Research Council

National Heart Foundation

Postgraduate Scholarship

Baker Heart and Diabetes Institute Bright Sparks Scholarship

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/6/542/27717214/ehy437.pdf

Reference29 articles.

1. Multicenter Automatic Defibrillator Implantation Trial III. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med,2002

2. Sudden Cardiac Death in Heart Failure Trial I. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

3. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy;Kadish;N Engl J Med,2004

4. Investigators AMIOVIRT. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia–AMIOVIRT;Strickberger;J Am Coll Cardiol,2003

5. Authors/Task Force M. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur Heart J,2016

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy;Heart Failure Clinics;2024-10

2. Heart failure, sudden cardiac death and implantable cardioverter-defibrillators: sex matters;Journal of Cardiovascular Medicine;2024-08-13

3. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias;Scientific Reports;2024-06-27

4. Arrhythmogenic Cardiomyopathy: Current Updates and Future Challenges;Reviews in Cardiovascular Medicine;2024-06-04

5. Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature;Reviews in Cardiovascular Medicine;2024-05-11